Global Anti-snoring Device Market Trends and Drivers, Restraints, and Opportunities 2018-2024
  • ID: 1188
  • February 15, 2018
  • 65 pages
  • Infoholic Research

Global Anti-snoring Devices Market – Drivers, Restraints, Opportunities, Trends, and Forecasts: 2018–2024
Overview: Snoring is a harsh noise formed due to the trembling of the muscular palate and pillars of the oropharyngeal inlet during sleep. A person is described as a habitual snorer if there is an occurrence of loud snoring at least three times in a week. This is majorly connected with obstructive sleep apnea (OSA). These habitual snorers experience excessive sleepiness in the daytime and can develop systemic hypertension in those aged below 50 years. Recently, studies have suggested that snoring can have risks of carotid atherosclerosis also. There have been many international epidemiological studies to establish the prevalence of habitual snoring.
When snoring is left untreated, it has multiple adverse consequences such as sleep apnea, stroke, systemic hypertension, atrial fibrillation, coronary artery disease, and others. Anti-snoring devices and surgery are the two types of treatment options available currently. These two methods help in the prevention of snoring and improve the quality of sleep. Uvulopalatopharyngoplasty surgery, radiofrequency ablation surgery, adenoidectomy surgery, maxillo-mandibular surgeries, and tonsillectomy are the alternatives for anti-snoring devices in the market.
The significant factors driving the progress of the market are increasing awareness about ill effects of snoring, mounting geriatric and obese population, increase in the number of smokers and alcoholics, and a huge volume of snoring population. However, the meager effectiveness of present anti-snoring devices accessible in the marketplace and the availability of alternative treatments for snoring are some of the factors hampering the market growth.
Market Analysis: The “Global Anti-snoring Devices Market” is estimated to witness a CAGR of 9.8% during the forecast period 2018–2024. The market is analyzed based on three segments – products, end-users, and regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America holds the major share of the anti-snoring devices market, followed by Europe. These two regions together hold three-fourth of revenue in the market. Asia Pacific is expected to have the fastest growth rate due to high infectious diseases prevalence, large patient pool, and increasing awareness. This is followed by Rest of the World in terms of the growth rate during the forecast period.
Product Analysis: Oral appliances, nasal devices, position control devices, chin straps, and EPAP devices are the types of products in the anti-snoring market. Mandibular advancement devices (MADs) and tongue retaining devices are the types of oral appliances in the market. Nasal dilators and nasal strips are the two types of nasal devices. Position pillows, anti-snoring belt, and bottom lines are the types of position control devices.
End-users Analysis: The hospitals & clinics is the largest application segment in 2017. The sleep clinics that recommend anti-snoring oral appliances to their patients have shown a positive success rate as high as 94%. However, this success rate may vary between individuals. Yet, there has been an increase in the demand for the home healthcare during the forecast period. This increase in home care has given rise to many technological advanced and portable products.
Key Players: Sleeping Well LLC, Apnea Sciences Corporation, Tomed GmbH, Sleep Well Enjoy Life Ltd., MEDiTAS, and GlaxoSmithKline are the key players in the market. SomnoMed Ltd., MPowerx, Thervent, Rhinomed Ltd., Hivox Biotek Inc., and Zyppah are other predominate & niche players.
Competitive Analysis: The oral appliances are the most used anti-snoring devices and held more than half of the share in 2017. Some of the key players in this segment include Apnea Sciences Corporation, Sleeping Well, Sleep Well Enjoy Life, Tomed GmbH, and MEDiTAS. Nasal devices are next to the oral appliances, which is led by GlaxoSmithKline.
Many companies are concentrating on product innovation to reinforce their spot in the market. For instance, Oventus Medical, based in Australia, has recently launched a 3D printed anti-snoring device named O2Vent that can be customized based on an individual’s need. It is a lightweight titanium device and can help patients stop snoring by delivering air to the back of his or her mouth. Such modernizations hold the great potential for the success of the company in the market.
Benefits: The report provides complete details about the usage and adoption rate of anti-snoring devices in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
Key Stakeholders:

Table of Contents
1 Industry Outlook 8
1.1 Industry Overview 8
1.2 Industry Trends 9
2 Report Outline 11
2.1 Report Scope 11
2.2 Report Summary 11
2.3 Research Methodology 12
2.4 Report Assumptions 12
3 Market Snapshot 14
3.1 Segmented Addressable Market 14
3.2 Industry Trends 15
3.3 Related Markets 16
3.3.1 Nebulizers 16
3.3.2 Continuous positive airway pressure (CPAP) 16
3.3.3 Sleep Apnea 17
3.3.4 Pulmonary Medicine 18
4 Market Outlook 19
4.1 Market Definition – Infoholic Research 19
4.2 Market Overview 19
4.3 Causes of Snoring 20
4.4 Market Segmentation 21
4.5 Porter 5(Five) Forces 22
4.6 PEST Analysis 23
5 Market Characteristics 24
5.1 Market Dynamics 24
5.1.1 Drivers 24
5.1.1.1 Increasing usage of oral appliances 24
5.1.1.2 Growing awareness about ill-effects of snoring 25
5.1.1.3 High prevalence of tobacco smoking 25
5.1.1.4 In expensive nature of the devices 25
5.1.2 Opportunities 26
5.1.2.1 Rising Ageing and Obese Population 26
5.1.2.2 Emerging Markets in Developing Countries 26
5.1.3 Restraints 27
5.1.3.1 Poor Effectiveness of Existing Anti-Snoring Devices in The Market 27
5.1.3.2 Alternative Treatment for Snoring 27
5.2 DRO – Impact Analysis 28
5.3 Key Stakeholders 29
6 Product: Market Size and Analysis 30
6.1 Overview 30
6.2 Oral Appliances 30
6.2.1 Mandibular Advancement Devices (MAD) 31
6.2.2 Tongue Stabilizing Devices 32
6.3 Nasal Devices 33
6.3.1 Nasal Dilator 33
6.3.2 Nasal Strips 34
6.4 Position Control Devices 34
6.5 Chin Straps 34
6.6 EPAP Therapy Devices 35
7 End-users: Market Size and Analysis 36
7.1 Overview 36
7.2 Hospitals and clinics 36
7.3 Home Care 36
8 Regions: Market Size and Analysis 38
8.1 Overview 38
8.2 North America 40
8.2.1 Overview 40
8.2.2 United States 41
8.2.3 Canada 42
8.3 Europe 42
8.3.1 Overview 42
8.3.2 UK 43
8.3.3 Germany 43
8.3.4 France 43
8.4 Asia Pacific 43
8.4.1 Overview 43
8.4.2 India 44
8.4.3 Japan 45
8.4.4 China 45
8.4.5 Australia 45
8.5 Rest of the World 46
8.5.1 Overview 46
8.5.2 Brazil 46
8.5.3 Middle East 47
9 Competitive Landscape 48
10 Vendors Profile 49
10.1 GlaxoSmithKline plc 49
10.1.1 Overview 49
10.1.2 Geographic Presence 53
10.1.3 Business Focus 53
10.1.4 SWOT Analysis 54
10.1.5 Business Strategy 54
10.2 Meditas 55
10.2.1 Overview 55
10.3 Sleeping Well LLC 56
10.3.1 Overview 56
10.4 Apnea Sciences Corporation 56
10.4.1 Overview 56
10.5 SomnoMed Ltd. 57
10.5.1 Overview 57
10.6 Tomed GmbH 58
10.6.1 Overview 58
10.7 MPowerx 58
10.7.1 Overview 58
10.8 Theravent 59
10.8.1 Overview 59
10.9 Sleep Well Enjoy Life Ltd 59
10.9.1 Overview 59
10.10 Rhinomed Ltd 60
10.10.1 Overview 60
10.10.2 Highlights 61
10.11 Hivox Biotek Inc. 61
10.11.1 Overview 61
10.12 ZYPPAH 62
10.12.1 Overview 62
Annexure 63
Abbreviations 63

Tables

TABLE 1 COST COMPERISION OF VARIOUS TREATMENT FOR SNORING 26
TABLE 2 MANDIBULAR ADVANCEMENT DEVICES (MAD) AVAILABLE IN THE MARKET 31
TABLE 3 TOP 3 NASAL DILATORS IN THE MARKET ARE 33
TABLE 4 ANTI-SNORING DEVICES MARKET REVENUE BY REGIONS, 2017–2024 ($MILLION) 40
TABLE 5 GLAXOSMITHKLINE PLC: OFFERINGS 50
TABLE 6 GLAXOSMITHKLINE PLC: RECENT DEVELOPMENTS 50
TABLE 7 MEDITAS: OVERVIEW 55
TABLE 8 SLEEPING WELL LLC: OVERVIEW 56
TABLE 9 APNEA SCIENCE CORPORATION: OVERVIEW 56
TABLE 10 SOMNOMED LTD.: OVERVIEW 57
TABLE 11 SOMNOMED LTD.: RECENT DEVELOPMENTS 57
TABLE 12 TOMED GMBH: OVERVIEW 58
TABLE 13 MPOWERX: OVERVIEW 59
TABLE 14 THERAVENT: OVERVIEW 59
TABLE 15 SLEEP WELL ENJOY LIFE LTD: OVERVIEW 60
TABLE 16 RHINOMED LTD: OVERVIEW 60
TABLE 17 HIVOX BIOTEK INC: OVERVIEW 61
TABLE 18 ZYPPAH: OVERVIEW 62

Charts

CHART 1 RESEARCH METHODOLOGY OF GLOBAL ANTI-SNORING DEVICES MARKET 12
CHART 2 GLOBAL ANTI-SNORING DEVICES MARKET REVENUE, 2017-2024($MILLION) 15
CHART 3 SEGMENTATION OF GLOBAL ANTI-SNORING DEVICES MARKET 21
CHART 4 PORTER 5 FORCES OF GLOBAL ANTI-SNORING DEVICES MARKET 22
CHART 5 PEST ANALYSIS OF ANTI-SNORING DEVICES MARKET 23
CHART 6 MARKET DYNAMICS – DRO ANALYSIS 24
CHART 7 DRO – IMPACT ANALYSIS OF GLOBAL ANTI-SNORING DEVICES MARKET 28
CHART 8 KEY STAKEHOLDERS 29
CHART 9 ANTI-SNORING DEVICES MARKET SEGMENT SHARE, 2016 (%) 30
CHART 10 GLOBAL ANTI-SNORING DEVICES MARKET BY END-USER SEGMENTATION, 2017 36
CHART 11 PREVALANCE OF HABITUAL SNORERING IN VARIOUS COUNTRIES-2015 38
CHART 12 GLOBAL ANTI-SNORING DEVICES MARKET BY REGIONAL SEGMENTATION, 2016 (%) 39
CHART 13 GLOBAL ANTI-SNORING DEVICES MARKET BY REGIONAL SEGMENTATION, 2016 (%) 39
CHART 14 ANTI-SNORING DEVICES MARKET REVENUE IN NORTH AMERICA, 2017-2024 ($MILLION) 41
CHART 15 ANTI-SNORING DEVICES MARKET REVENUE IN EUROPE, 2017-2024 ($MILLION) 42
CHART 16 ANTI-SNORING DEVICES MARKET REVENUE IN ASIA PACIFIC, 2017-2024 ($MILLION) 44
CHART 17 ANTI-SNORING DEVICES MARKET REVENUE IN REST OF THE WORLD, 2017-2024 ($MILLION) 46
CHART 18 GLAXOSMITHKLINE PLC: OVERVIEW SNAPSHOT 50
CHART 19 GLAXOSMITHKLINE PLC: BUSINESS UNITS 51
CHART 20 GLAXOSMITHKLINE PLC: GEOGRAPHIC PRESENCE 53
CHART 21 GLAXOSMITHKLINE PLC: SWOT ANALYSIS 54

None

"Global Anti-snoring Device Market Trends and Drivers, Restraints, and Opportunities 2018-2024
"

Custom Research

Looking for more specific research study and analysis? Contact our Custom Research Team

Write to Custom Research Team